The Economics of Bladder Cancer: Costs and Considerations of Caring for This Disease
Top Cited Papers
- 23 January 2014
- journal article
- review article
- Published by Elsevier BV in European Urology
- Vol. 66 (2), 253-262
- https://doi.org/10.1016/j.eururo.2014.01.006
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of MaintenanceEuropean Urology, 2012
- Long-Term Decrease in Bladder Cancer Recurrence with Hexaminolevulinate Enabled Fluorescence CystoscopyJournal of Urology, 2012
- Quality of care in patients with bladder cancerCancer, 2011
- EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 UpdateEuropean Urology, 2011
- Projections of the Cost of Cancer Care in the United States: 2010-2020JNCI Journal of the National Cancer Institute, 2011
- Patterns of care for early stage bladder cancerCancer, 2010
- Treatment of nonmuscle invading bladder cancer: Do physicians in the United States practice evidence based medicine?Cancer, 2009
- Provider Treatment Intensity and Outcomes for Patients With Early-Stage Bladder CancerJNCI Journal of the National Cancer Institute, 2009
- Economic aspects of bladder cancer: what are the benefits and costs?World Journal of Urology, 2009
- Estimates and Projections of Value of Life Lost From Cancer Deaths in the United StatesJNCI Journal of the National Cancer Institute, 2008